15 August 2022 - - Boston-based 501c3 nonprofit biotech Cure Rare Disease (CRD) has received approval from the US Food and Drug Administration to administer its very first therapeutic, the company said.
The drug, named CRD-TMH-001, ...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
15 August 2022 - - The journal Cancer Biotherapy and Radiopharmaceuticals has published a manuscript by US-based BioMarker Strategies' scientists entitled "Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict ...
15 August 2022 - Biotechnology company Novavax Inc (Nasdaq:NVAX) said on Monday that it has applied to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its COVID-19 vaccine to be as a booster dose.If approved, it wou...
15 August 2022 - Medical technology company Boston Scientific Corporation (NYSE: BSX) reported on Monday that it has acquired Obsidio Inc, a privately-held company that has developed the Gel Embolic Material (GEM) technology used for embolization of ...
15 August 2022 - An arbitrator issued a decision on Friday in a dispute between Japan-based pharmaceutical company Daiichi Sankyo Company, Ltd. And American biotechnology company Seagen, Inc., denying all claims made by Seagen.Specifically, Daiichi S...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe